Cargando…

COVID-19 and coronaviral hepatitis: evidence of collateral damage

Detalles Bibliográficos
Autor principal:	Parvez, Mohammad K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291768/ http://dx.doi.org/10.2217/fvl-2020-0065

Ejemplares similares

Systemic Viral Infections and Collateral Damage in the Liver
por: Adams, David H., et al.
Publicado: (2006)

Rotaviral and Coronaviral Diarrhea
por: Torres-Medina, Alfonso, et al.
Publicado: (1985)

Challenging beliefs and ethical concepts: the collateral damage of SARS
por: Bernstein, Mark, et al.
Publicado: (2003)

Controversy in coronaViral Imaging and Diagnostics (COVID)
por: Hamilton, M.C.K., et al.
Publicado: (2020)

Social inequalities and collateral damages of the COVID-19 pandemic: when basic needs challenge mental health care
por: Cénat, Jude Mary, et al.
Publicado: (2020)

Natural killer cell granules converge to avoid collateral damage
por: Ritter, Alex T., et al.
Publicado: (2016)

Collateral Health Issues Derived from the Covid-19 Pandemic
por: Muniz-Pardos, Borja, et al.
Publicado: (2020)

Re: Controversy in coronaViral Imaging and Diagnostics (COVID)
por: Morozov, S., et al.
Publicado: (2020)

Vitamin D: evidence for an association with coronary collateral circulation development?
por: Lima, Jose, et al.
Publicado: (2015)

Ferret Systemic Coronaviral Disease (FSCD)
Publicado: (2013)

Lithium and coronaviral infections. A scoping review.
por: Nowak, Jan K., et al.
Publicado: (2020)

COVID-19-induced collateral damage
Publicado: (2020)

Coronaviral Infection and Interferon Response: The Virus-Host Arms Race and COVID-19
por: Liu, Qi, et al.
Publicado: (2022)

“Anosmia” the mysterious collateral damage of COVID-19
por: Ahmed, Abdulrahman K., et al.
Publicado: (2022)

Re: Controversy in coronaViral Imaging and Diagnostics (COVID). A reply
por: Hamilton, M.C.K., et al.
Publicado: (2020)

Host proteases as determinants of coronaviral neurotropism and virulence
por: Vavougios, George D.
Publicado: (2020)

Neuroimmune multi-hit perspective of coronaviral infection
por: Hayley, Shawn, et al.
Publicado: (2021)

Coronaviral RNA-methyltransferases: function, structure and inhibition
por: Nencka, Radim, et al.
Publicado: (2022)

An unusual collateral damage of COVID-19 pandemic
por: Medas, Renato, et al.
Publicado: (2020)

Cardiovascular Collateral Damages at the Time of COVID-19
por: Jacques, Frédéric, et al.
Publicado: (2020)

Medical education-collateral damage of COVID-19?
por: Ding, Anni
Publicado: (2020)

Seeking Normalcy as the Curve Flattens: Ethical Considerations for Pediatricians Managing Collateral Damage of Coronavirus Disease-2019
por: Feltman, Dalia M., et al.
Publicado: (2020)

The Potential of Developing Pan-Coronaviral Antibodies to Spike Peptides in Convalescent COVID-19 Patients
por: Rabets, Andrii, et al.
Publicado: (2021)

Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity
por: Yang, Cheng-Wei, et al.
Publicado: (2017)

Feline Infectious Peritonitis: An Immune-Mediated Coronaviral Vasculitis
por: August, John R.
Publicado: (1984)

Therapeutic Potential of Glycosyl Flavonoids as Anti-Coronaviral Agents
por: Godinho, Patrícia I. C., et al.
Publicado: (2021)

Non-communicable diseases viewed as “collateral damage” of our decisions: Fixing accountabilities and finding sloutions in primary care settings
por: Bhattacharya, Sudip, et al.
Publicado: (2020)

The cognitive consequences of the COVID-19 epidemic: collateral damage?
por: Ritchie, Karen, et al.
Publicado: (2020)

Clinical research: further COVID-19 collateral damage
por: The Lancet Gastroenterology & Hepatology
Publicado: (2020)

Stigma-discrimination: Significant collateral damage of COVID-19
por: Cassiani-Miranda, Carlos Arturo, et al.
Publicado: (2020)

Collateral damage for failing to do in the times of COVID-19
por: Mira, J.J., et al.
Publicado: (2021)

Collateral cardiovascular damage during the COVID-19 pandemic
por: Nadarajah, Ramesh, et al.
Publicado: (2021)

COVID‐19 and children: medical impact and collateral damage
por: Brüssow, Harald
Publicado: (2022)

Fixing accountabilities and finding solutions to tackle acute (communicable) diseases viewed as collateral damage due to errors of omission and commission in primary care
por: Bhattacharya, Sudip, et al.
Publicado: (2019)

Collateral effects and ethical challenges in healthcare due to COVID-19 – A dire need to support healthcare workers and systems
por: Chandy, Sujith J., et al.
Publicado: (2021)

Regulation of Coronaviral Poly(A) Tail Length during Infection
por: Wu, Hung-Yi, et al.
Publicado: (2013)

Membrane and Phospholipid Binding by Murine Coronaviral Nucleocapsid N Protein
por: Anderson, Robert, et al.
Publicado: (1993)

Modulation of lysosomal function as a therapeutic approach for coronaviral infections
por: Liu, Yuan, et al.
Publicado: (2021)

Concerns About Coronavirus Disease–Related Collateral Damage for Patients With COPD
por: Press, Valerie G., et al.
Publicado: (2020)

The Collateral Damage of the COVID-19 Outbreak on Mental Health and Psychiatry
por: Simon, Frederick A. J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lc2phcbu3a4o4lmuvgnlubpjsn